相似文献
1
A new era in maternal-child health: Abrysvo's role in RSV prevention.
Health Sci Rep. 2024 Jul 3;7(7):e2236. doi: 10.1002/hsr2.2236. eCollection 2024 Jul.
2
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19.
Curr Opin Infect Dis. 2023 Dec 1;36(6):522-528. doi: 10.1097/QCO.0000000000000967. Epub 2023 Oct 13.
3
Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions.
J Paediatr Child Health. 2022 Oct;58(10):1741-1746. doi: 10.1111/jpc.16197. Epub 2022 Sep 8.
4
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
Front Immunol. 2022 Apr 28;13:880368. doi: 10.3389/fimmu.2022.880368. eCollection 2022.
5
Maternal RSV vaccine development. Where to from here?
Hum Vaccin Immunother. 2021 Nov 2;17(11):4542-4548. doi: 10.1080/21645515.2021.1955608. Epub 2021 Sep 9.
6
Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
Vaccine. 2021 Jul 13;39(31):4383-4390. doi: 10.1016/j.vaccine.2021.05.100. Epub 2021 Jun 17.
7
Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.
Vaccine. 2022 Jul 30;40(32):4361-4370. doi: 10.1016/j.vaccine.2022.06.034. Epub 2022 Jun 17.
8
Adjustable Algorithmic Tool for Assessing the Effectiveness of Maternal Respiratory Syncytial Virus (RSV) Vaccination on Infant Mortality in Developing Countries.
Infect Dis Obstet Gynecol. 2021 May 24;2021:5536633. doi: 10.1155/2021/5536633. eCollection 2021.
9
Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain.
Infect Dis Ther. 2024 Jun;13(6):1315-1331. doi: 10.1007/s40121-024-00975-6. Epub 2024 May 11.
10
Clinical research on RSV prevention in children and pregnant women: progress and perspectives.
Front Immunol. 2024 Jan 24;14:1329426. doi: 10.3389/fimmu.2023.1329426. eCollection 2023.
引用本文的文献
1
Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus.
FASEB J. 2025 Jul 31;39(14):e70858. doi: 10.1096/fj.202500509RR.
2
A bivalent mRNA vaccine against RSV infection in rodent models.
Front Immunol. 2025 Mar 24;16:1542592. doi: 10.3389/fimmu.2025.1542592. eCollection 2025.
3
Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue.
MedComm (2020). 2024 Nov 21;5(12):e70016. doi: 10.1002/mco2.70016. eCollection 2024 Dec.
本文引用的文献
1
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5.
2
Clinical features of respiratory syncytial virus bronchiolitis in an infant: rapid and fatal brain involvement.
BMC Pediatr. 2021 Dec 9;21(1):556. doi: 10.1186/s12887-021-03045-9.
3
Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
J Infect Dis. 2019 Oct 22;220(11):1802-1815. doi: 10.1093/infdis/jiz390.
4
Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy.
Emerg Infect Dis. 2015 Nov;21(11):1951-5. doi: 10.3201/eid2111.150497.
Zotero 插件